Search
for
Sort by
Research 121–150 of 444
- An Update of Congenital Adrenal Hyperplasia
- Physiologic skin changes in pregnancy
- Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
- Central Opioid Inhibition of Neuroendocrine Stress Responses in Pregnancy in the Rat Is Induced by the Neurosteroid Allopregnanolone
- Neurogenic Inflammation in Stress-Induced Termination of Murine Hair Growth Is Promoted by Nerve Growth Factor
- Baiting Proteins with C<sub>60</sub>
- Congenital Adrenal Hyperplasia
- Obesity and polycystic ovary syndrome
- <i>Polycystic Ovary Syndrome in Adolescence</i>
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Safety of testosterone treatment in postmenopausal women
- Side-Effects of Spironolactone Therapy in the Hirsute Woman
- Acne and Systemic Disease
- Physiological and biological skin changes in pregnancy
- Semen Parameters Among Transgender Women With a History of Hormonal Treatment
- Stress-related skin disorders
- PHYSIOLOGIC SKIN CHANGES ASSOCIATED WITH PREGNANCY
- Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
- Fadrozole and finasteride exposures modulate sex steroid- and thyroid hormone-related gene expression in Silurana (Xenopus) tropicalis early larval development
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Nonclassic adrenal hyperplasia
- 46,XY DSD due to impaired androgen production
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Nonclassic Congenital Adrenal Hyperplasia
- Neuroimmunoregulation of Androgens in the Adrenal Gland and the Skin
- Chrousos syndrome: from molecular pathogenesis to therapeutic management